Literature DB >> 25380145

Finger pointing to JC virus: a tale of two indexes.

Igor J Koralnik1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25380145      PMCID： PMC4427895          DOI： 10.1002/ana.24302

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  17 in total

1.  Risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Gary Bloomgren; Sandra Richman; Christophe Hotermans; Meena Subramanyam; Susan Goelz; Amy Natarajan; Sophia Lee; Tatiana Plavina; James V Scanlon; Alfred Sandrock; Carmen Bozic
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

Review 2.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

3.  Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus.

Authors:  R S Hamilton; M Gravell; E O Major
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.

Authors:  Raphael P Viscidi; Dana E M Rollison; Emma Viscidi; Barbara Clayman; Elizabeth Rubalcaba; Richard Daniel; Eugene O Major; Keerti V Shah
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

5.  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy.

Authors:  B L Padgett; D L Walker
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

6.  Anti-JC virus antibodies: implications for PML risk stratification.

Authors:  Leonid Gorelik; Michaela Lerner; Sarah Bixler; Mary Crossman; Brian Schlain; Kenneth Simon; Amy Pace; Anne Cheung; Ling Ling Chen; Melissa Berman; Fairuz Zein; Ewa Wilson; Ted Yednock; Alfred Sandrock; Susan E Goelz; Meena Subramanyam
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

7.  JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals.

Authors:  Raphael P Viscidi; Nina Khanna; Chen S Tan; Xiuhung Li; Lisa Jacobson; David B Clifford; Avindra Nath; Joseph B Margolick; Keerti V Shah; Hans H Hirsch; Igor J Koralnik
Journal:  Clin Infect Dis       Date:  2011-08-18       Impact factor: 9.079

Review 8.  Progressive multifocal leukoencephalopathy: why gray and white matter.

Authors:  Sarah Gheuens; Christian Wüthrich; Igor J Koralnik
Journal:  Annu Rev Pathol       Date:  2012-10-18       Impact factor: 23.472

9.  Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.

Authors:  Wendy A Knowles; Pam Pipkin; Nick Andrews; Andrew Vyse; Philip Minor; David W G Brown; Elizabeth Miller
Journal:  J Med Virol       Date:  2003-09       Impact factor: 2.327

10.  Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Tatiana Plavina; Meena Subramanyam; Gary Bloomgren; Sandra Richman; Amy Pace; Sophia Lee; Brian Schlain; Denise Campagnolo; Shibeshih Belachew; Barry Ticho
Journal:  Ann Neurol       Date:  2014-10-24       Impact factor: 10.422
View more
  3 in total

1.  JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.

Authors:  Elena Uleri; Gabriele Ibba; Claudia Piu; Maurizio Caocci; Stefania Leoni; Giannina Arru; Caterina Serra; GianPietro Sechi; Antonina Dolei
Journal:  J Neurovirol       Date:  2016-11-03       Impact factor: 2.643

Review 2.  Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate.

Authors:  Thorsten Bartsch; Torge Rempe; Arne Wrede; Frank Leypoldt; Wolfgang Brück; Ortwin Adams; Axel Rohr; Olav Jansen; Christian Wüthrich; Günther Deuschl; Igor J Koralnik
Journal:  Ann Neurol       Date:  2015-07-31       Impact factor: 10.422

3.  JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus.

Authors:  Maria A Zingaropoli; Marco Iannetta; Simona Pontecorvo; Elena Anzivino; Carla Prezioso; Donatella Maria Rodio; Manuela Morreale; Alessandra D'Abramo; Alessandra Oliva; Miriam Lichtner; Antonio Cortese; Marco Frontoni; Valeria Pietropaolo; Ada Francia; Claudio M Mastroianni; Vincenzo Vullo; Maria R Ciardi
Journal:  Biomed Res Int       Date:  2018-02-27       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.